Decompression vs. Fusion for Stable Degenerative Spondylolisthesis

May 1, 2026 updated by: University Health Network, Toronto

Decompression Alone vs. Decompression and Instrumented Fusion for the Management of Lumbar Spinal Stenosis Associated With Stable Degenerative Spondylolisthesis: A Pragmatic Randomized Clinical Pilot Trial

The purpose of this study is to assess the feasibility of a full-scale multicenter randomized, controlled trial comparing the effectiveness of two surgical treatments for a condition associated with lumbar spinal stenosis called degenerative lumbar spondylolisthesis. Both treatments are currently used, but individual surgeons use different selection criteria for each treatment and use the procedures at different rates. The two procedures are decompression with fusion (the most common surgical procedure for spondylolisthesis) and midline-sparing decompression alone (which is also a standard treatment, but is not as widely used for treating spondylolisthesis). The investigators plan to collect the evidence on the following:

  1. The feasibility of the trial protocol, and
  2. Preliminary data on the effectiveness of each treatment.

Study Overview

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Calgary, Alberta, Canada, T2N 2N9
        • Foothills Medical Centre
      • Edmonton, Alberta, Canada, T6G 2B7
        • Mackenzie Health Sciences Centre
    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z 1M9
        • Vancouver General Hospital
    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3H 2Y9
        • Queen Elizabeth II Health Sciences Centre
    • Ontario
      • London, Ontario, Canada, N6A 5W9
        • London Health Sciences Centre - Victoria Hospital
      • Toronto, Ontario, Canada, M4N 3M5
        • Sunnybrook Health Sciences Centre
      • Toronto, Ontario, Canada, M5T 2S8
        • University Health Network
    • Quebec
      • Montreal, Quebec, Canada, H3G 1A4
        • Montreal General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

46 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients deemed to be surgical candidates with focal (1-2 level) lumbar spinal stenosis (LSS) and associated stable degenerative spondylolisthesis with the following characteristics:

    1. a clinical history of back, buttock and leg pain with walking or standing that is improved when lying, sitting or bending forward
    2. a clinical history of leg symptoms that are greater than or equal to back symptoms with walking or standing, and
    3. greater than 6 months of symptoms with failed conservative care
  • aged 50 or over
  • sufficient fluency in English or French to provide informed consent and complete questionnaires with or without the need of an interpreter

Exclusion Criteria:

  • Greater than 25% listhesis or spinal instability as demonstrated by motion (>5mm of translation) on flexion extension radiographs or non-loaded (MRI/CT or supine x-rays) to loaded imaging (standing radiograph)
  • Presence of kyphosis (>0 degrees at the affected level or globally), degenerative scoliosis (>10 degree using the Cobb method) with rotatory or lateral listhesis on preoperative x-rays
  • Clinical history of osteoporotic fracture or chronic oral steroid use
  • Previous posterior lumbar spinal surgery (excluding prior microdiscectomy)
  • Patients who have evidence of neurological disorders that affect physical function (e.g. peripheral neuropathy), neuromuscular disorders (e.g. multiple sclerosis, Parkinson's etc.) or systemic illness (e.g. inflammatory arthritis) that affects physical function

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Decompression with fusion
Spinal decompression surgery with instrumented spinal fusion
Active Comparator: Decompression alone
Midline-sparing spinal decompression alone

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients recruited
Time Frame: 1 year
1 year
Number of eligible patients
Time Frame: 1 year
1 year
Reasons for refusal to consent
Time Frame: 1 year
1 year
Proportion of patients who adhere to randomized allocation
Time Frame: 2 years
2 years
Number of patients refusing to consent due to blinding
Time Frame: 1 year
1 year
Blinding status
Time Frame: 1.5 months post-surgery
Patient's assessment of which treatment they received
1.5 months post-surgery
Oswestry Disability Index (ODI)
Time Frame: 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
10-item patient-reported questionnaire measuring disability related to low back pain. Each item has six response options ranging from 0 to 5; the responses are summed and rescaled so 0 indicates no disability and 100 indicates extreme disability.
6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
Proportion of patients who receive randomized allocation
Time Frame: 2 years
2 years
Number of patients refusing to consent due to randomization
Time Frame: 1 year
1 year
Number, type and severity of adverse events
Time Frame: End of hospital stay (average 6.5 days post-surgery)
End of hospital stay (average 6.5 days post-surgery)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short-Form 12 scores: Physical Function, Bodily Pain, Physical Component Summary
Time Frame: Baseline; 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
12-item patient-reported questionnaire for general health status based on the SF-36 Health Survey (version 2). Measures eight health domains, each scored so 0 is the worst and 100 is the best possible score: general health (GH), physical function (PF), bodily pain (BP), role limitations due to physical problems (RP), role limitations due to emotional problems (RE), mental health (MH), social functioning (SF), and energy/fatigue (VT). The domain scores can be aggregated into Physical Component Summary (PCS) and Mental Component Summary (MCS) scores, also scaled so 0 is the worst and 100 is the best possible score. This study will focus primarily on the Physical Function domain, the Bodily Pain domain, and the Physical Component Summary score.
Baseline; 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
Euro-QoL health utility index
Time Frame: Baseline; 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
Patient-reported questionnaire for general health state which includes five items (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and a visual analog scale for self-rated health state. Using an existing U.S. population-based value set, responses will be converted to the corresponding health utility index (1.0=perfect health and 0.0=death).
Baseline; 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
Patient Health Questionnaire-9 score
Time Frame: Baseline
Patient-reported questionnaire that measures severity of depression symptoms. It is scored from 0 to 27, with the following interpretation: 0-4=no symptoms, 5-9=minimal symptoms; 10-14=mild/minor depression or dysthymia; 15-19=moderate major depression; 20-27=severe major depression.
Baseline
Costs incurred by patients
Time Frame: monthly from 1.5 to 12 months post-surgery; 24 months post-surgery
monthly from 1.5 to 12 months post-surgery; 24 months post-surgery
Hospital cost
Time Frame: End of hospital stay (average 6.5 days post-surgery)
End of hospital stay (average 6.5 days post-surgery)
Healthcare services used
Time Frame: Referral to 1 year post-surgery
Other Ontario Health Insurance Plan (OHIP)-billed services used
Referral to 1 year post-surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yoga Raja Rampersaud, MD FRCSC, University Health Network, Toronto
  • Principal Investigator: Anthony Perruccio, PhD, University Health Network, Toronto

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2015

Primary Completion (Actual)

August 1, 2023

Study Completion (Actual)

August 1, 2023

Study Registration Dates

First Submitted

September 9, 2014

First Submitted That Met QC Criteria

January 22, 2015

First Posted (Estimated)

January 28, 2015

Study Record Updates

Last Update Posted (Actual)

May 7, 2026

Last Update Submitted That Met QC Criteria

May 1, 2026

Last Verified

May 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Stenosis

Clinical Trials on Spinal fusion

Subscribe